Cantitate/Preț
Produs

Formulation of Monoclonal Antibody Therapies: From Lab to Market

Autor Amal Ali Elkordy
en Limba Engleză Paperback – 23 mai 2023
Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies, and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. It also covers the industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases, and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences.


  • Covers details of recent advances in using mAbs
  • Examines how to overcome the challenges for formulations of therapeutic mAbs
  • Includes clinical application of mAbs
Citește tot Restrânge

Preț: 72277 lei

Preț vechi: 97847 lei
-26%

Puncte Express: 1084

Preț estimativ în valută:
13847 15033$ 11875£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128233658
ISBN-10: 0128233656
Pagini: 346
Ilustrații: 25 illustrations (5 in full color)
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE

Cuprins

1. Introduction about monoclonal antibodies
2. Biosimilar antibodies
3. Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies
4. Route of monoclonal antibodies administration
5. Industrial aspects of finished monoclonal antibody therapies
6. Application of approved and marketed products of monoclonal antibody therapies